$2.59
-0.03-1.15%
Last update: Nov 2, 8:53 AM
OnKure Therapeutics Inc
OKURNASDAQ
OnKure Therapeutics (OKUR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.62 | $-0.76 | $-1.15 | $-1.20 |
| Actual | $-0.31 | $-1.11 | $-0.99 | $-1.09 |
| Surprise | +50.0% | -46.1% | +13.9% | +9.17% |
| Revenue | ||||
| Estimate | $200000 | $200000 | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.39 | $-0.41 | $-0.31 | $-0.32 |
| Revenue | ||||
| Consensus | $200000 | $200000 | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $-0.31 | $-0.62 | 50.0 % |
| Q1 | May 5, 2026 | $-1.11 | $-0.76 | -46.1 % |
| Q4 | Mar 12, 2026 | $-0.99 | $-1.15 | 13.9 % |
| Q3 | Nov 6, 2025 | $-1.09 | $-1.20 | 9.17 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0 | $200.00K | -100.0 % |
| Q1 | May 5, 2026 | $0 | $200.00K | -100.0 % |
